Related Experiment Video

Updated: Oct 21, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

R Maserati1, A E Cagni, C Segú

  • 1Infectious Disease Department, IRCCS Policlinico San Matteo, University of Pavia, Italy.

Chemotherapy
|March 1, 1996
PubMed

Insights

Sparfloxacin effectively treated methicillin-resistant Staphylococcus aureus (MRSA) endocarditis in rabbits. This new quinolone antibiotic showed comparable efficacy to vancomycin in reducing bacterial counts in aortic vegetations.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Microbiology

Background:

  • Catheter-induced endocarditis is a serious infection.
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant treatment challenge.
  • Novel antibiotics are needed to combat resistant bacterial infections.

Purpose of the Study:

  • To evaluate the efficacy of sparfloxacin in treating MRSA endocarditis.
  • To compare sparfloxacin with vancomycin in a rabbit model.

Main Methods:

  • A rabbit model of catheter-induced endocarditis was used.
  • Infection was induced with a methicillin-resistant Staphylococcus aureus (MRSA) strain.
  • Animals were treated with intravenous sparfloxacin, vancomycin, or left untreated.

Main Results:

  • Both sparfloxacin and vancomycin significantly reduced bacterial counts in aortic vegetations compared to controls.
  • No significant difference in efficacy was observed between sparfloxacin and vancomycin.
  • Combination therapy did not show additional benefits over single-drug treatment.

Conclusions:

  • Sparfloxacin demonstrates potential as a therapeutic agent for MRSA endocardial infections.
  • The study provides evidence for sparfloxacin's efficacy in a relevant animal model.
  • Further investigation into sparfloxacin for MRSA infections is warranted.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Assay Development for High-Throughput Drug Screening Against Mycobacteria07:50

Assay Development for High-Throughput Drug Screening Against Mycobacteria

Published on: October 25, 2024

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...